These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 14617689

  • 1. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
    Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ.
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
    [Abstract] [Full Text] [Related]

  • 2. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [Abstract] [Full Text] [Related]

  • 3. Nicotinamide induces apoptosis and reduces collagen I and pro-inflammatory cytokines expression in rat hepatic stellate cells.
    Traister A, Breitman I, Bar-Lev E, Zvibel I, Harel A, Halpern Z, Oren R.
    Scand J Gastroenterol; 2005 Oct; 40(10):1226-34. PubMed ID: 16165703
    [Abstract] [Full Text] [Related]

  • 4. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA, Liu D, Zhou QY, Huang SF, Luo P, Xiang Y, Sun S, Luo D, Dong YF, Zhang LP.
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [Abstract] [Full Text] [Related]

  • 5. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
    Anan A, Baskin-Bey ES, Isomoto H, Mott JL, Bronk SF, Albrecht JH, Gores GJ.
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G709-16. PubMed ID: 16798723
    [Abstract] [Full Text] [Related]

  • 6. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 7. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 8. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I, Uemoto S.
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [Abstract] [Full Text] [Related]

  • 9. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.
    Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ.
    Gastroenterology; 2002 Oct; 123(4):1323-30. PubMed ID: 12360492
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Paik YH, Kim JK, Lee JI, Kang SH, Kim DY, An SH, Lee SJ, Lee DK, Han KH, Chon CY, Lee SI, Lee KS, Brenner DA.
    Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
    [Abstract] [Full Text] [Related]

  • 11. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
    Yu J, Hui AY, Chu ES, Go MY, Cheung KF, Wu CW, Chan HL, Sung JJ.
    Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.
    Trebicka J, Hennenberg M, Odenthal M, Shir K, Klein S, Granzow M, Vogt A, Dienes HP, Lammert F, Reichen J, Heller J, Sauerbruch T.
    J Hepatol; 2010 Oct; 53(4):702-12. PubMed ID: 20633948
    [Abstract] [Full Text] [Related]

  • 13. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.
    Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ.
    Hepatology; 2003 Nov; 38(5):1188-98. PubMed ID: 14578857
    [Abstract] [Full Text] [Related]

  • 14. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis.
    Patella S, Phillips DJ, Tchongue J, de Kretser DM, Sievert W.
    Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G137-44. PubMed ID: 16123203
    [Abstract] [Full Text] [Related]

  • 15. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T, Beljaars L, van de Bovenkamp M, Temming K, van Loenen AM, Reker-Smit C, Meijer DK, Lacombe M, Opdam F, Kéri G, Orfi L, Poelstra K, Kok RJ.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [Abstract] [Full Text] [Related]

  • 16. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R.
    BMC Gastroenterol; 2003 Oct 18; 3():29. PubMed ID: 14565855
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
    Lee TY, Lee KC, Chang HH.
    Apoptosis; 2010 Aug 18; 15(8):904-14. PubMed ID: 20446039
    [Abstract] [Full Text] [Related]

  • 18. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
    Osawa Y, Seki E, Adachi M, Taura K, Kodama Y, Siegmund SV, Schwabe RF, Brenner DA.
    Liver Int; 2006 Nov 18; 26(9):1138-47. PubMed ID: 17032415
    [Abstract] [Full Text] [Related]

  • 19. [Effect of antioxidant on hepatic stellate cell proliferation and apoptosis during recovery from liver fibrosis].
    Shen XH, Cheng WF, Li XH, Xie LM, Sun J, Li F, Ma L.
    Wei Sheng Yan Jiu; 2005 Mar 18; 34(2):194-6. PubMed ID: 15952662
    [Abstract] [Full Text] [Related]

  • 20. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM, Zhang QS, Lee NP, Wo JY, Leung PP, Liu LX, Hu MY, Cheung KF, Hui CK, Lau GK, Fan ST.
    Liver Int; 2007 May 18; 27(4):548-57. PubMed ID: 17403195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.